Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
By
Shengjun Hong,
Dmitry Prokopenko,
Valerija Dobricic,
Fabian Kilpert,
Isabelle Bos,
Stephanie J. B. Vos,
Betty Tijms,
Ulf Andreasson,
Kaj Blennow,
Rik Vandenberghe,
Isabelle Cleynen,
Silvy Gabel,
Jolien Schaeverbeke,
Philip Scheltens,
Charlotte E. Teunissen,
Ellis Niemantsverdriet,
Sebastiaan Engelborghs,
Giovanni Frisoni,
Olivier Blin,
Jill C. Richardson,
Regis Bordet,
José Luis Molinuevo,
Lorena Rami,
Alzheimer’s Disease Neuroimaging Initiative (ADNI),
Petronella Kettunen,
Anders Wallin,
Alberto Lleó,
Isabel Sala,
Julius Popp,
Gwendoline Peyratout,
Pablo Martinez-Lage,
Mikel Tainta,
Richard J. B. Dobson,
Cristina Legido-Quigley,
Kristel Sleegers,
Christine Van Broeckhoven,
Mara ten Kate,
Frederik Barkhof,
Henrik Zetterberg,
Simon Lovestone,
Johannes Streffer,
Michael Wittig,
Andre Franke,
Rudolph E. Tanzi,
Pieter Jelle Visser,
Lars Bertram
Posted 23 Sep 2019
bioRxiv DOI: 10.1101/774554
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. Elucidating the genetic architecture of additional AD-related phenotypic traits, ideally those linked to the underlying disease process, holds great promise in gaining deeper insights into the genetic basis of AD and in developing better clinical prediction models. To this end, we generated genome-wide single-nucleotide polymorphism (SNP) genotyping data in 931 participants of the European Medical Information Framework Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) sample to search for novel genetic determinants of AD biomarker variability. Specifically, we performed genome-wide association study (GWAS) analyses on 16 traits, including 14 measures of amyloid-beta (Aβ) and tau-protein species in the cerebrospinal fluid (CSF). In addition to confirming the well-established effects of apolipoprotein E (APOE) on diagnostic outcome and phenotypes related to Aβ42, we detected novel potential signals in the zinc finger homeobox 3 (ZFHX3) for CSF-Aβ38 and CSF-Aβ40 levels, and confirmed the previously described sex-specific association between SNPs in geminin coiled-coil domain containing (GMNC) and CSF-tau. Utilizing the results from independent case-control AD GWAS to construct polygenic risk scores (PRS) revealed that AD risk variants only explain a small fraction of CSF biomarker variability. In conclusion, our study represents a detailed first account of GWAS analyses on CSF-Aβ and -tau related traits in the EMIF-AD MBD dataset. In subsequent work, we will utilize the genomics data generated here in GWAS of other AD-relevant clinical outcomes ascertained in this unique dataset.
Download data
- Downloaded 632 times
- Download rankings, all-time:
- Site-wide: 49,694
- In genomics: 3,822
- Year to date:
- Site-wide: 104,731
- Since beginning of last month:
- Site-wide: 146,567
Altmetric data
Downloads over time
Distribution of downloads per paper, site-wide
PanLingua
News
- 27 Nov 2020: The website and API now include results pulled from medRxiv as well as bioRxiv.
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!